Shire Biotech Denmark ApS: Financial statements 2013
CVR: 33358008
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Shire Biotech Denmark ApS (CVR 33358008) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 4,752,701 and a net result of DKK 231,818 compared with DKK 92,990 the year before. That is an increase of 14.7% compared with the year before. Equity in the 2013 report amounted to DKK 560,587. The solvency ratio was 12.2%.
- Gross Profit
- DKK 4,752,701
- Profit/Loss
- DKK 231,818
- Equity
- DKK 560,587
- Total Assets
- DKK 4,584,088
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of December 4, 2013, John Erik Mattias Bankel has joined the board of directors of Shire Biotech Denmark ApS.
As of December 4, 2013, Mary Christine Di Marzio has left the board of directors of Shire Biotech Denmark ApS.
As of December 4, 2013, John Erik Mattias Bankel is registered as direktion of Shire Biotech Denmark ApS.
As of December 4, 2013, Mary Christine Di Marzio has stepped down as direktion of Shire Biotech Denmark ApS.
Shire Biotech Denmark ApS has published its annual report for 2012. Revenue came to DKK 4,145,110, and the net result was DKK 92,990.
About Shire Biotech Denmark ApS
Shire Biotech Denmark ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company has been dissolved on 1 April 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SHIRE DENMARK ApS and ApS STAKE NR. 1347. The company has 0 employees (2018). In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. Equity in the 2017 report amounted to DKK 3,207,794.